Company profile
Viridian Therapeutics, Inc.\DE Insider Trading
VRDNEvery SEC Form 4 insider trading filing for Viridian Therapeutics, Inc.\DE (VRDN) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001590750
- Filings
- 60
- Insiders
- 20
- Last filing
- 2026-08-19
Activity summary
No insider transactions in the last 30 days. The most recent was on August 19, 2026, when Jennifer Tousignant sold 4,212 shares. 60 filings from 20 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Viridian Therapeutics, Inc.\DE insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $40.0M.
90 day insight
Over the last 90 days, Viridian Therapeutics, Inc.\DE insiders bought $673K (10 transactions) and sold $348K (2 transactions).
- Most active insider: Jennifer Tousignant with 4 transactions totaling $492K.
- Largest single purchase: $528K by Radhika Tripuraneni on Aug 14, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Jennifer Tousignant | VRDN | Sale | 4,212 | $24.50 | $103K |
| Aug 19, 2026 | Jennifer Tousignant | VRDN | Option Exercise | 10,000 | $14.41 | $144K |
| Aug 19, 2026 | Jennifer Tousignant | VRDN | Sale | 10,000 | $24.50 | $245K |
| Aug 19, 2026 | Jennifer Tousignant | VRDN | Option Exercise | 10,000 | — | — |
| Aug 14, 2026 | Radhika Tripuraneni | VRDN | Option Exercise | 40,000 | $13.21 | $528K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=VRDN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Viridian Therapeutics, Inc.\DE as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →